Cargando…

Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?

Detalles Bibliográficos
Autor principal: Patoulias, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369027/
https://www.ncbi.nlm.nih.gov/pubmed/34447672
http://dx.doi.org/10.14218/JCTH.2021.00236
_version_ 1783739204553932800
author Patoulias, Dimitrios
author_facet Patoulias, Dimitrios
author_sort Patoulias, Dimitrios
collection PubMed
description
format Online
Article
Text
id pubmed-8369027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-83690272021-08-25 Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken? Patoulias, Dimitrios J Clin Transl Hepatol Editorial XIA & HE Publishing Inc. 2021-08-28 2021-08-03 /pmc/articles/PMC8369027/ /pubmed/34447672 http://dx.doi.org/10.14218/JCTH.2021.00236 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Patoulias, Dimitrios
Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title_full Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title_fullStr Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title_full_unstemmed Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title_short Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
title_sort serum resistin as a biomarker in nonalcoholic fatty liver disease: is this a road to be taken?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369027/
https://www.ncbi.nlm.nih.gov/pubmed/34447672
http://dx.doi.org/10.14218/JCTH.2021.00236
work_keys_str_mv AT patouliasdimitrios serumresistinasabiomarkerinnonalcoholicfattyliverdiseaseisthisaroadtobetaken